These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25295422)

  • 1. Antidepressant augmentation with anti-inflammatory agents.
    Andrade C
    J Clin Psychiatry; 2014 Sep; 75(9):975-7. PubMed ID: 25295422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo.
    Fourrier C; Sampson E; Mills NT; Baune BT
    Trials; 2018 Aug; 19(1):447. PubMed ID: 30126458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using non-steroidal anti-inflammatory drugs in the treatment of depression.
    Davis A; Gilhooley M; Agius M
    Psychiatr Danub; 2010 Nov; 22 Suppl 1():S49-52. PubMed ID: 21057403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant response in patients with major depression exposed to NSAIDs: a pharmacovigilance study.
    Gallagher PJ; Castro V; Fava M; Weilburg JB; Murphy SN; Gainer VS; Churchill SE; Kohane IS; Iosifescu DV; Smoller JW; Perlis RH
    Am J Psychiatry; 2012 Oct; 169(10):1065-72. PubMed ID: 23032386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder.
    Lyoo IK; Yoon S; Kim TS; Hwang J; Kim JE; Won W; Bae S; Renshaw PF
    Am J Psychiatry; 2012 Sep; 169(9):937-945. PubMed ID: 22864465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation and combination strategies in treatment-resistant depression.
    Fava M
    J Clin Psychiatry; 2001; 62 Suppl 18():4-11. PubMed ID: 11575733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
    Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
    Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies.
    Connolly KR; Thase ME
    Drugs; 2011 Jan; 71(1):43-64. PubMed ID: 21175239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of antidepressant drugs in schizophrenic patients with depression].
    Micallef J; Fakra E; Blin O
    Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agomelatine versus other antidepressive agents for major depression.
    Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD008851. PubMed ID: 24343836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of antidepressants in the treatment of major depressive disorder: a systematic review and meta-analysis.
    Rocha FL; Fuzikawa C; Riera R; Hara C
    J Clin Psychopharmacol; 2012 Apr; 32(2):278-81. PubMed ID: 22367652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder.
    Papakostas GI
    J Clin Psychiatry; 2009; 70 Suppl 6():16-25. PubMed ID: 19922740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of atypical antipsychotics in depressive syndromes].
    Quintin P; Thomas P
    Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
    Richards C; McIntyre RS; Weisler R; Sambunaris A; Brawman-Mintzer O; Gao J; Geibel B; Dauphin M; Madhoo M
    J Affect Disord; 2016 Dec; 206():151-160. PubMed ID: 27474961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder.
    De Berardis D; Orsolini L; Serroni N; Girinelli G; Iasevoli F; Tomasetti C; de Bartolomeis A; Mazza M; Valchera A; Fornaro M; Perna G; Piersanti M; Di Nicola M; Cavuto M; Martinotti G; Di Giannantonio M
    CNS Neurol Disord Drug Targets; 2016; 15(1):35-44. PubMed ID: 26295824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Milnacipran versus other antidepressive agents for depression.
    Nakagawa A; Watanabe N; Omori IM; Barbui C; Cipriani A; McGuire H; Churchill R; Furukawa TA
    Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD006529. PubMed ID: 19588396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial.
    Papakostas GI; Mischoulon D; Shyu I; Alpert JE; Fava M
    Am J Psychiatry; 2010 Aug; 167(8):942-8. PubMed ID: 20595412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of antidepressant nonresponders: augmentation or switch?
    Nelson JC
    J Clin Psychiatry; 1998; 59 Suppl 15():35-41. PubMed ID: 9786309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant medication exposure and 5-HT
    Metts AV; Rubin-Falcone H; Ogden RT; Lin X; Wilner DE; Burke AK; Sublette ME; Oquendo MA; Miller JM; Mann JJ
    Synapse; 2019 Jun; 73(6):e22089. PubMed ID: 30693567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
    Papakostas GI; Thase ME; Fava M; Nelson JC; Shelton RC
    Biol Psychiatry; 2007 Dec; 62(11):1217-27. PubMed ID: 17588546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.